{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:20Z","timestamp":1772166320347,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Toronto Pettit Block Term Grant"},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["128701"],"award-info":[{"award-number":["128701"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare genetic bone disease that is characterized by progressive heterotopic ossification of the thoracic cavity. Prognosis is poor with cardiopulmonary complications being the main cause of death. Spirometry is a well-established metric of functional exercise capacity and prognosis in lung diseases but its use is limited in this population. Accuracy and validity of spirometry is dependent on forced expiratory maneuvers which are difficult to perform for individuals with FOP. Oscillometry is an effort-independent pulmonary function test that is highly sensitive to changes in respiratory mechanics. Little is known about oscillometry in individuals with FOP. The purpose of this paper is to characterize FOP using oscillometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eight participants with FOP were recruited for oscillometry prior to spirometry. Cumulative Analogue Joint Involvement Scale (CAJIS) scores\u00a0were used to evaluate total body and regional FOP burden. Spirometry showed a uniform pattern of restrictive physiology in all eight participants with no significant difference amongst the group. Oscillometry revealed significant diversity in respiratory mechanics and chest wall involvement from normal, airway obstruction and ventilatory inhomogeneity to extra-thoracic airflow obstruction. We compared individuals with normal and abnormal oscillometry and found no statistically significant differences in functional status and clinical parameters. However, there is a tendency for lower CAJIS scores and fewer recent flare-ups in those with more normal respiratory mechanics. The tidal volumes were significantly higher in the group with more normal respiratory mechanics. Two wheelchair-dependent participants exhibited a pattern of high respiratory resistance that increased during both inspiration and expiration, to suggest presence of a fixed extra-thoracic defect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Oscillometry provides additional, more detailed information beyond spirometry in individuals with FOP. It is far easier than spirometry to complete and may be useful to help track disease progression and response to therapies in individuals with FOP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03846-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:02:43Z","timestamp":1751346163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Respiratory oscillometry in individuals with fibrodysplasia ossificans progressiva"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5915-9265","authenticated-orcid":false,"given":"Anastasiia","family":"Vasileva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4113-2531","authenticated-orcid":false,"given":"Joyce K. Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7389-9800","authenticated-orcid":false,"given":"Melissa","family":"Valaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3772-4039","authenticated-orcid":false,"given":"Ethan","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5696-7750","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Hantos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianne","family":"Tile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8332-0744","authenticated-orcid":false,"given":"Angela M.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9344-8522","authenticated-orcid":false,"given":"Chung-Wai","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"2","key":"3846_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.29245\/2572-9411\/2020\/2.1196","volume":"5","author":"M Liljesthr\u00f6m","year":"2020","unstructured":"Liljesthr\u00f6m M, Pignolo RJ, Kaplan FS. Epidemiology of the Global fibrodysplasia ossificans progressiva (FOP) community. J Rare Dis Res Treat. 2020;5(2):31\u20136.","journal-title":"J Rare Dis Res Treat"},{"issue":"3","key":"3846_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.2106\/JBJS.I.00705","volume":"92","author":"FS Kaplan","year":"2010","unstructured":"Kaplan FS, Zasloff MA, Kitterman JA, Shore EM, Hong CC, Rocke DM. Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am. 2010;92(3):686\u201391.","journal-title":"J Bone Joint Surg Am"},{"key":"3846_CR3","first-page":"865","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism \u2013","author":"FS Kaplan","year":"2019","unstructured":"Kaplan FS, Pignolo RJ, Al Mukaddam M, Shore EM. Genetic disorders of heterotopic ossification: fibrodysplasia ossificans progressiva and progressive osseous heteroplasia. In: Bilezikian J, editor. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism \u2013. 9th ed. Washington, D.C.: The American Society for Bone and Mineral Research; 2019. p. 865\u201370.","edition":"9"},{"issue":"Suppl 2","key":"3846_CR4","first-page":"437","volume":"10","author":"RJ Pignolo","year":"2013","unstructured":"Pignolo RJ, Shore EM, Kaplan FS. Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatric Endocrinol Rev\u202f: PER. 2013;10(Suppl 2):437\u201348.","journal-title":"Pediatric Endocrinol Rev : PER"},{"issue":"6","key":"3846_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/thx.36.6.419","volume":"36","author":"JM Connor","year":"1981","unstructured":"Connor JM, Evans CC, Evans DA. Cardiopulmonary function in fibrodysplasia ossificans progressiva. Thorax. 1981;36(6):419\u201323.","journal-title":"Thorax"},{"issue":"3","key":"3846_CR6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jbmr.2728","volume":"31","author":"RJ Pignolo","year":"2016","unstructured":"Pignolo RJ, Bedford-Gay C, Liljesthrom M, et al. The natural history of flare-ups in fibrodysplasia ossificans progressiva (FOP): A comprehensive global assessment. J Bone Mineral Res\u202f: Official J Amer Soc Bone Mineral Res. 2016;31(3):650\u20136.","journal-title":"J Bone Mineral Res : Official J Amer Soc Bone Mineral Res"},{"key":"3846_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115274","volume":"134","author":"RJ Pignolo","year":"2020","unstructured":"Pignolo RJ, Cheung K, Kile S, et al. Self-reported baseline phenotypes from the International Fibrodysplasia Ossificans Progressiva (FOP) Association Global Registry. Bone. 2020;134: 115274.","journal-title":"Bone"},{"issue":"11","key":"3846_CR8","first-page":"3462","volume":"119","author":"Q Shen","year":"2009","unstructured":"Shen Q, Little SC, Xu M, et al. The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Investig. 2009;119(11):3462\u201372.","journal-title":"J Clin Investig"},{"issue":"10","key":"3846_CR9","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/jbmr.4655","volume":"37","author":"RJ Pignolo","year":"2020","unstructured":"Pignolo RJ, Baujat G, Hsiao EC, Keen R, Wilson A, Packman J, Strahs AL, Grogan DR, Kaplan FS. Palovarotene for fibrodysplasia ossificans progressiva (FOP): results of a randomized, placebo-controlled, double-blind phase 2 trial. J Bone Mineral Res. 2020;37(10):1891\u2013902.","journal-title":"J Bone Mineral Res"},{"issue":"3","key":"3846_CR10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jbmr.4762","volume":"38","author":"RJ Pignolo","year":"2023","unstructured":"Pignolo RJ, Hsiao EC, Al Mukaddam M, Baujat G, Berglund SK, Brown MA, Brown MA, Cheung AM, De Cunto C, Delai P, Haga N, Kannu P. Reduction of new heterotopic ossification (HO) in the open-label, phase 3 MOVE trial of palovarotene for fibrodysplasia ossificans progressiva (FOP). J Bone Mineral Res. 2023;38(3):381\u201394.","journal-title":"J Bone Mineral Res"},{"issue":"1","key":"3846_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12969-023-00856-1","volume":"21","author":"IP Nikishina","year":"2023","unstructured":"Nikishina IP, Arsenyeva SV, Matkava VG, Arefieva AN, Kaleda MI, Smirnov AV, Blank LM, Kostik MM. Successful experience of tofacitinib treatment in patients with fibrodysplasia ossificans progressiva. Pediatr Rheumatol Online J. 2023;21(1):92.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"3846_CR12","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1038\/s41591-023-02561-8","volume":"29","author":"M Di Rocco","year":"2023","unstructured":"Di Rocco M, Forleo-Neto E, Pignolo RJ, Keen R, Orcel P, Funck-Brentano T, Kaplan FS. Garetosmab in fibrodysplasia ossificans progressiva: A randomized, double-blind, placebo-controlled phase 2 trial. Nat Med. 2023;29(10):2615\u201324.","journal-title":"Nat Med"},{"key":"3846_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/00003086-199801000-00015","volume":"346","author":"WG Kussmaul","year":"1998","unstructured":"Kussmaul WG, Esmail AN, Sagar Y, Ross J, Gregory S, Kaplan FS. Pulmonary and cardiac function in advanced fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 1998;346:104\u20139.","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"3846_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1164\/arrd.1974.110.3.333","volume":"110","author":"WJ Buhain","year":"1974","unstructured":"Buhain WJ, Rammohan G, Berger HW. Pulmonary function in myositis ossificans progressiva. Am Rev Respir Dis. 1974;110(3):333\u20137.","journal-title":"Am Rev Respir Dis"},{"key":"3846_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2021.100758","volume":"14","author":"E Botman","year":"2021","unstructured":"Botman E, Smilde BJ, Hoebink M, et al. Deterioration of pulmonary function: An early complication in Fibrodysplasia Ossificans Progressiva. Bone Rep. 2021;14: 100758.","journal-title":"Bone Rep"},{"issue":"3","key":"3846_CR16","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/j.2040-4603.2011.tb00366.x","volume":"1","author":"JH Bates","year":"2011","unstructured":"Bates JH, Irvin CG, Farre R, Hantos Z. Oscillation mechanics of the respiratory system. Compr Physiol. 2011;1(3):1233\u201372.","journal-title":"Compr Physiol"},{"issue":"3","key":"3846_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jaci.2011.11.002","volume":"129","author":"Y Shi","year":"2012","unstructured":"Shi Y, Aledia AS, Tatavoosian AV, Vijayalakshmi S, Galant SP, George SC. Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol. 2012;129(3):671\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3846_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.anai.2019.12.017","volume":"124","author":"CR Kuo","year":"2020","unstructured":"Kuo CR, Lipworth B. Airwave oscillometry and patient-reported outcomes in persistent asthma. Annals Allergy Asthma Immunol. 2020;124(3):289\u201390.","journal-title":"Annals Allergy Asthma Immunol"},{"issue":"8","key":"3846_CR19","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1164\/rccm.201812-2322OC","volume":"200","author":"BH Foy","year":"2019","unstructured":"Foy BH, Soares M, Bordas R, et al. Lung computational models and the role of the small airways in asthma. Am J Respir Crit Care Med. 2019;200(8):982\u201391.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"3846_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/resp.13772","volume":"25","author":"FSM Tang","year":"2020","unstructured":"Tang FSM, Rutting S, Farrow CE, et al. Ventilation heterogeneity and oscillometry predict asthma control improvement following step-up inhaled therapy in uncontrolled asthma. Respirology. 2020;25(8):827\u201335.","journal-title":"Respirology"},{"issue":"8","key":"3846_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.rmed.2012.04.010","volume":"106","author":"S Frantz","year":"2012","unstructured":"Frantz S, Nihlen U, Dencker M, Engstrom G, Lofdahl CG, Wollmer P. Impulse oscillometry may be of value in detecting early manifestations of COPD. Respir Med. 2012;106(8):1116\u201323.","journal-title":"Respir Med"},{"issue":"3","key":"3846_CR22","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1183\/09031936.00051214","volume":"45","author":"BB Aarli","year":"2015","unstructured":"Aarli BB, Calverley PMA, Jensen RL, Eagan TML, Bakke PS, Hardie JA. Variability of within- breath reactance in COPD patients and its association with dyspnoea. Eur Respir J. 2015;45(3):625\u201334.","journal-title":"Eur Respir J"},{"key":"3846_CR23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.2147\/COPD.S137865","volume":"12","author":"J Dean","year":"2017","unstructured":"Dean J, Kolsum U, Hitchen P, Gupta V, Singh D. Clinical characteristics of COPD patients with tidal expiratory flow limitation. Int J Chron Obstruct Pulmon Dis. 2017;12:1503\u20136.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3846_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/japplphysiol.01031.2017","volume":"125","author":"H Young","year":"2018","unstructured":"Young H, Guo F, Eddy R, Maksym G, Parraga G. Oscillometry and pulmonary MRI measurements of ventilation heterogeneity in obstructive lung disease: relationship to quality of life and disease control. J Appl Physiol. 2018;125:73\u201385. https:\/\/doi.org\/10.1152\/japplphysiol.01031.2017.","journal-title":"J Appl Physiol"},{"issue":"1","key":"3846_CR25","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13955","volume":"7","author":"RL Eddy","year":"2019","unstructured":"Eddy RL, Westcott A, Maksym GN, Parraga G, Dandurand RJ. Oscillometry and pulmonary magnetic resonance imaging in asthma and COPD. Physiol Rep. 2019;7(1): e13955.","journal-title":"Physiol Rep"},{"issue":"1","key":"3846_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2021-001163","volume":"9","author":"JK Wu","year":"2022","unstructured":"Wu JK, Ma J, Nguyen L, Dehaas EL, Vasileva A, Chang E, Liang J, Huang QW, Cassano A, Binnie M, Shapera S. Correlation of respiratory oscillometry with CT image analysis in a prospective cohort of idiopathic pulmonary fibrosis. BMJ Open Respir Res. 2022;9(1): e001163.","journal-title":"BMJ Open Respir Res"},{"issue":"6","key":"3846_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1183\/09031936.03.00089403","volume":"22","author":"E Oostveen","year":"2003","unstructured":"Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J. 2003;22(6):1026\u201341.","journal-title":"Eur Respir J"},{"key":"3846_CR28","doi-asserted-by":"publisher","first-page":"1900753","DOI":"10.1183\/13993003.00753-2019","volume":"55","author":"GG King","year":"2020","unstructured":"King GG, Bates J, Berger KI, Calverley P, de Melo PL, Dellac\u00e0 RL, et al. Technical standards for respiratory oscillometry. Eur Respir J. 2020;55:1900753.","journal-title":"Eur Respir J"},{"key":"3846_CR29","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.4187\/respcare.07412","volume":"65","author":"JK Wu","year":"2020","unstructured":"Wu JK, DeHaas E, Nadj R, Cheung AB, Dandurand RJ, Hantos Z, et al. Development of quality assurance and quality control guidelines for respiratory oscillometry in clinic studies. Respir Care. 2020;65:1687\u201393. https:\/\/doi.org\/10.4187\/respcare.07412.","journal-title":"Respir Care"},{"key":"3846_CR30","volume":"182","author":"E Chang","year":"2022","unstructured":"Chang E, Vasileva A, Nohra C, Ryan CM, Chow CW, Wu JKY. Conducting respiratory oscillometry in an outpatient setting. JoVE (J Visual Exper). 2022;182: e63243.","journal-title":"JoVE (J Visual Exper)"},{"key":"3846_CR31","doi-asserted-by":"crossref","unstructured":"Hantos, Z., Wu, J. K., Dandurand, R. J., & Chow, C. W. (2023). Quality control in respiratory oscillometry: reproducibility measures ignoring reactance?.\u00a0ERJ Open Research,\u00a09(3).","DOI":"10.1183\/23120541.00070-2023"},{"key":"3846_CR32","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 Update. An official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200:e70-88. https:\/\/doi.org\/10.1164\/rccm.201908-1590ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3846_CR33","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1183\/09031936.00126212","volume":"42","author":"E Oostveen","year":"2013","unstructured":"Oostveen E, Boda K, van der Grinten CP, et al. Respiratory impedance in healthy subjects: baseline values and bronchodilator response. Eur Respir J. 2013;42(6):1513\u201323.","journal-title":"Eur Respir J"},{"issue":"12","key":"3846_CR34","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/ppul.20926","volume":"43","author":"B Nowowiejska","year":"2008","unstructured":"Nowowiejska B, Tomalak W, Radli\u0144ski J, Siergiejko G, Latawiec W, Kaczmarski M. Transient reference values for impulse oscillometry for children aged 3\u201318 years. Pediatr Pulmonol. 2008;43(12):1193\u20137.","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"3846_CR35","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343. https:\/\/doi.org\/10.1183\/09031936.00080312.","journal-title":"Eur Respir J"},{"key":"3846_CR36","doi-asserted-by":"crossref","unstructured":"Kaminsky, D.A., Simpson, S.J., Berger, K.I., Calverley, P., De Melo, P.L., Dandurand, R., Dellac\u00e0, R.L., Farah, C.S., Farr\u00e9, R., Hall, G.L. and Ioan, I., 2022. Clinical significance and applications of oscillometry.\u00a0European Respiratory Review,\u00a031(163).","DOI":"10.1183\/16000617.0208-2021"},{"key":"3846_CR37","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevBiomedEng.v39.i4.30","author":"JHT Bates","year":"2011","unstructured":"Bates JHT, Maksym GN. Mechanical determinants of airways hyperresponsiveness. Critical ReviewsTM Biomed Eng. 2011. https:\/\/doi.org\/10.1615\/CritRevBiomedEng.v39.i4.30.","journal-title":"Critical ReviewsTM Biomed Eng"},{"key":"3846_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2021.05.004","volume":"22","author":"Z Hantos","year":"2021","unstructured":"Hantos Z. Intra-breath oscillometry for assessing respiratory outcomes. Curr Opin Physio. 2021;22: 100441.","journal-title":"Curr Opin Physio"},{"key":"3846_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bone.2017.04.015","volume":"101","author":"FS Kaplan","year":"2017","unstructured":"Kaplan FS, Al Mukaddam M, Pignolo RJ. A cumulative analogue joint involvement scale (CAJIS) for fibrodysplasia ossificans progressiva (FOP). Bone. 2017;101:123\u20138.","journal-title":"Bone"},{"key":"3846_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bone.2017.09.014","volume":"109","author":"RJ Pignolo","year":"2018","unstructured":"Pignolo RJ, Kaplan FS. Clinical staging of fibrodysplasia ossificans progressiva (FOP). Bone. 2018;109:111\u20134.","journal-title":"Bone"},{"issue":"49","key":"3846_CR41","volume":"22","author":"JKY Wu","year":"2024","unstructured":"Wu JKY, Xu JJ, Vasileva A, Nohra C, Binnie M, Shapera S, Fisher JH, Ryan CM, McInnis M, Hantos Z, Chow CW. Respiratory oscillometry with CT image analysis in idiopathic pulmonary fibrosis following single lung transplant. Respir Med Case Rep. 2024;22(49): 102016.","journal-title":"Respir Med Case Rep"},{"issue":"4","key":"3846_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1152\/jappl.1964.19.4.653","volume":"19","author":"BG Ferris Jr","year":"1964","unstructured":"Ferris BG Jr, Mead J, Opie LH. Partitioning of respiratory flow resistance in man. J Appl Physiol. 1964;19(4):653\u20138.","journal-title":"J Appl Physiol"},{"issue":"3","key":"3846_CR43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1152\/jappl.1980.49.3.408","volume":"49","author":"J Nagels","year":"1980","unstructured":"Nagels J, Landser FJ, Van der Linden L, Clement J, Van de Woestijne KP. Mechanical properties of lungs and chest wall during spontaneous breathing. J Appl Physiol. 1980;49(3):408\u201316.","journal-title":"J Appl Physiol"},{"issue":"1","key":"3846_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1152\/jappl.1986.60.1.123","volume":"60","author":"Z Hantos","year":"1986","unstructured":"Hantos Z, Daroczy B, Suki B, Galgoczy G, Csendes T. Forced oscillatory impedance of the respiratory system at low frequencies. J Appl Physiol. 1986;60(1):123\u201332.","journal-title":"J Appl Physiol"},{"issue":"8","key":"3846_CR45","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1183\/09031936.93.04080945","volume":"4","author":"JA Van Noord","year":"1991","unstructured":"Van Noord JA, Cauberghs M, Van de Woestijne KP, Demedts M. Total respiratory resistance and reactance in ankylosing spondylitis and kyphoscoliosis. Eur Respir J. 1991;4(8):945\u201351.","journal-title":"Eur Respir J"},{"key":"3846_CR46","doi-asserted-by":"publisher","first-page":"1301873","DOI":"10.3389\/fmed.2023.1301873","volume":"10","author":"S Storoni","year":"2023","unstructured":"Storoni S, Verdonk SJ, Micha D, Jak PM, Bugiani M, Eekhoff EM, van den Aardweg JG. Bronchial obstruction in osteogenesis imperfecta can be detected by forced oscillation technique. Front Med. 2023;10:1301873.","journal-title":"Front Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03846-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03846-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03846-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T05:02:48Z","timestamp":1751346168000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03846-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3846"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03846-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5753372\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University Health Network (UHN) Research Ethics Board (#19\u20135582 and 17\u20135652). The participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AMC: consultant fees Ipsen, grants to UHN from Ipsen and Incyte for the clinical trials in FOP; CWC: speaker honoraria from AstraZeneca Canada and Covis Pharma, investigator-initiated research grant from Thorasys Thoracic Medical Devices Corp. (held at UHN); JW: speaker honoraria from Covis Pharma; consultant fees from Thorasys Thoracic Medical Devices Corp; ZH: consultant fees from Thorasys Thoracic Medical Devices Corp and Piston Medical Ltd.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}